{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T03:47:11Z","timestamp":1795232831463,"version":"4.10.3"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007452","name":"Wu Jieping Medical Foundation","doi-asserted-by":"publisher","award":["320.6750.18315"],"award-info":[{"award-number":["320.6750.18315"]}],"id":[{"id":"10.13039\/100007452","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014761","name":"Natural Science Foundation of Qingdao Municipality","doi-asserted-by":"publisher","award":["24-4-4-zrjj-159-jch"],"award-info":[{"award-number":["24-4-4-zrjj-159-jch"]}],"id":[{"id":"10.13039\/501100014761","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ijbiomac.2026.151362","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T07:59:49Z","timestamp":1773129589000},"page":"151362","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["AS1411-aptamer-functionalized DNA tetrahedron for targeted delivery of vorinostat to suppress gastric cancer progression via ferroptosis induction and epithelial-mesenchymal transition inhibition"],"prefix":"10.1016","volume":"354","author":[{"given":"Tengkai","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufei","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingao","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runcheng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaoyang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2026.151362_bb0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ijbiomac.2026.151362_bb0010","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/imr.13280","article-title":"Targeting ferroptosis in gastric cancer: strategies and opportunities","volume":"321","author":"Le","year":"2024","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.ijbiomac.2026.151362_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2020.100715","article-title":"Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance","volume":"53","author":"Erin","year":"2020","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.ijbiomac.2026.151362_bb0020","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/3920664","article-title":"Ferritinophagy-mediated ferroptosis and activation of Keap1\/Nrf2\/HO-1 pathway were conducive to EMT inhibition of gastric cancer cells in action of 2,2\u2032-di-pyridineketone hydrazone dithiocarbamate butyric acid ester","volume":"2022","author":"Guan","year":"2022","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.ijbiomac.2026.151362_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119504","article-title":"Epigenetic modulation and understanding of HDAC inhibitors in cancer therapy","volume":"277","author":"Ramaiah","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.ijbiomac.2026.151362_bb0030","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a026831","article-title":"HDACs and HDAC inhibitors in cancer development and therapy","volume":"6","author":"Li","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.ijbiomac.2026.151362_bb0035","doi-asserted-by":"crossref","first-page":"12460","DOI":"10.1021\/acs.jmedchem.0c00830","article-title":"Thirty years of HDAC inhibitors: 2020 insight and hindsight","volume":"63","author":"Ho","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2026.151362_bb0040","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.drudis.2021.08.004","article-title":"Vorinostat in autophagic cell death: a critical insight into autophagy-mediated, -associated and -dependent cell death for cancer prevention","volume":"27","author":"Patra","year":"2022","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ijbiomac.2026.151362_bb0045","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.1002\/jps.23265","article-title":"Vorinostat with sustained exposure and high solubility in poly(ethylene glycol)-b-poly(DL-lactic acid) micelle nanocarriers: characterization and effects on pharmacokinetics in rat serum and urine","volume":"101","author":"Mohamed","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2026.151362_bb0050","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12951-024-02365-z","article-title":"Tetrahedral framework nucleic acids for improving wound healing","volume":"22","author":"Zou","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ijbiomac.2026.151362_bb0055","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.actbio.2025.02.011","article-title":"DNA tetrahedron nanomedicine for enhanced antitumor and antimetastatic effect through the amplification of mitochondrial oxidative stress","volume":"195","author":"Chen","year":"2025","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ijbiomac.2026.151362_bb0060","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1080\/17425247.2023.2276285","article-title":"Recent progress and application of the tetrahedral framework nucleic acid materials on drug delivery","volume":"20","author":"Li","year":"2023","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ijbiomac.2026.151362_bb0065","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1217769","article-title":"Anti-nucleolin aptamer AS1411: an advancing therapeutic","volume":"10","author":"Van den Avont","year":"2023","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.ijbiomac.2026.151362_bb0070","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ijpharm.2016.11.027","article-title":"Polyethylenimine-functionalized carbon nanotubes tagged with AS1411 aptamer for combination gene and drug delivery into human gastric cancer cells","volume":"516","author":"Taghavi","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2026.151362_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105319","article-title":"High payload and targeted release of anthracyclines by aptamer-tethered DNA nanotrains \u2014 thermodynamic and release kinetic study","volume":"148","author":"Pei","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2026.151362_bb0080","article-title":"Insights on the molecular mechanisms of cytotoxicity induced by AS1411 linked to folate-functionalized DNA nanocages in cancer cells","volume":"54","author":"Unida","year":"2023","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ijbiomac.2026.151362_bb0085","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.apsb.2023.01.017","article-title":"Recent progress of aptamer\u2013drug conjugates in cancer therapy","volume":"13","author":"He","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ijbiomac.2026.151362_bb0090","doi-asserted-by":"crossref","first-page":"7781","DOI":"10.3390\/ijms21207781","article-title":"Toward G-quadruplex-based anticancer agents: biophysical and biological studies of novel AS1411 derivatives","volume":"21","author":"Ogloblina","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2026.151362_bb0095","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41419-023-05568-8","article-title":"Hippo pathway dysregulation in gastric cancer: from Helicobacter pylori infection to tumor promotion and progression","volume":"14","author":"Messina","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ijbiomac.2026.151362_bb0100","article-title":"N4-acetylcytidine drives glycolysis addiction in gastric cancer via NAT10\/SEPT9\/HIF-1\u03b1 positive feedback loop","volume":"10","author":"Yang","year":"2023","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.ijbiomac.2026.151362_bb0105","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.3390\/ijms21144902","article-title":"SOX2 and p53 expression control converges in PI3K\/AKT signaling with versatile implications for stemness and cancer","volume":"21","author":"Schaefer","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2026.151362_bb0110","doi-asserted-by":"crossref","first-page":"20999","DOI":"10.18632\/oncotarget.8236","article-title":"Transcription factor RUNX2 up-regulates chemokine receptor CXCR4 to promote invasive and metastatic potentials of human gastric cancer","volume":"7","author":"Guo","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijbiomac.2026.151362_bb0115","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1038\/s41418-022-01008-w","article-title":"Wnt\/beta-catenin signaling confers ferroptosis resistance by targeting GPX4 in gastric cancer","volume":"29","author":"Wang","year":"2022","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ijbiomac.2026.151362_bb0120","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1358\/dot.2007.43.9.1112980","article-title":"Vorinostat in cutaneous T-cell lymphoma","volume":"43","author":"Duvic","year":"2007","journal-title":"Drugs Today (Barc.)"},{"key":"10.1016\/j.ijbiomac.2026.151362_bb0125","doi-asserted-by":"crossref","first-page":"W357","DOI":"10.1093\/nar\/gkz382","article-title":"SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules","volume":"47","author":"Daina","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2026.151362_bb0130","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.9","article-title":"HDAC inhibitors induce tumor-cell-selective pro-apoptotic transcriptional responses","volume":"4","author":"Bolden","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ijbiomac.2026.151362_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101328","article-title":"Insight into the mechanism of ferroptosis inhibition by ferrostatin-1","volume":"28","author":"Miotto","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.ijbiomac.2026.151362_bb0140","doi-asserted-by":"crossref","first-page":"11935","DOI":"10.2147\/OTT.S269168","article-title":"MST4 regulates epithelial-mesenchymal transition of choriocarcinoma by mediating TGF-\u03b21 expression","volume":"13","author":"Yu","year":"2020","journal-title":"Onco. Targets Ther."},{"key":"10.1016\/j.ijbiomac.2026.151362_bb0145","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1038\/s41401-023-01062-1","article-title":"Aspirin triggers ferroptosis in hepatocellular carcinoma cells through restricting NF-\u03baB p65-activated SLC7A11 transcription","volume":"44","author":"Wang","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ijbiomac.2026.151362_bb0150","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ijsu.2015.04.050","article-title":"P53 suppresses cell proliferation, metastasis, and angiogenesis of osteosarcoma through inhibition of the PI3K\/AKT\/mTOR pathway","volume":"20","author":"Song","year":"2015","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.ijbiomac.2026.151362_bb0155","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature14344","article-title":"Ferroptosis as a p53-mediated activity during tumour suppression","volume":"520","author":"Jiang","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2026.151362_bb0160","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3892\/ijo.2017.4025","article-title":"Regulation of autophagy and EMT by the interplay between p53 and RAS during cancer progression (review)","volume":"51","author":"Zhang","year":"2017","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ijbiomac.2026.151362_bb0165","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0955-0674(03)00003-6","article-title":"Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation","volume":"15","author":"Brooks","year":"2003","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.ijbiomac.2026.151362_bb0170","article-title":"Histone deacetylase inhibitors inhibit the proliferation of gallbladder carcinoma cells by suppressing AKT\/mTOR signaling","volume":"10","author":"Zhang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2026.151362_bb0175","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1007\/s10495-013-0866-y","article-title":"The histone deacetylase inhibitor vorinostat prevents TNF\u03b1-induced necroptosis by regulating multiple signaling pathways","volume":"18","author":"Wang","year":"2013","journal-title":"Apoptosis"},{"key":"10.1016\/j.ijbiomac.2026.151362_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115807","article-title":"The novel small molecule BH3 mimetic nobiletin synergizes with vorinostat to induce apoptosis and autophagy in small cell lung cancer","volume":"216","author":"Li","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2026.151362_bb0185","doi-asserted-by":"crossref","first-page":"5610","DOI":"10.7150\/thno.34755","article-title":"Dual-targeted gold nanoprism for recognition of early apoptosis, dual-model imaging and precise cancer photothermal therapy","volume":"9","author":"Zhang","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.ijbiomac.2026.151362_bb0190","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41413-024-00319-7","article-title":"A DNA tetrahedron-based ferroptosis-suppressing nanoparticle: superior delivery of curcumin and alleviation of diabetic osteoporosis","volume":"12","author":"Li","year":"2024","journal-title":"Bone Res."},{"key":"10.1016\/j.ijbiomac.2026.151362_bb0195","doi-asserted-by":"crossref","first-page":"8617","DOI":"10.1158\/0008-5472.CAN-10-0920","article-title":"A new paradigm for aptamer therapeutic AS1411 action: uptake by macropinocytosis and its stimulation by a nucleolin-dependent mechanism","volume":"70","author":"Reyes-Reyes","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijbiomac.2026.151362_bb0200","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1158\/0008-5472.CAN-07-5723","article-title":"The nucleolin targeting aptamer AS1411 destabilizes Bcl-2 messenger RNA in human breast cancer cells","volume":"68","author":"Soundararajan","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijbiomac.2026.151362_bb0205","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/cjp2.325","article-title":"KLF2 inhibits colorectal cancer progression and metastasis by inducing ferroptosis via the PI3K\/AKT signaling pathway","volume":"9","author":"Li","year":"2023","journal-title":"J. Pathol. Clin. Res."},{"key":"10.1016\/j.ijbiomac.2026.151362_bb0210","doi-asserted-by":"crossref","first-page":"5107","DOI":"10.7150\/thno.44705","article-title":"Combinative treatment of \u03b2-elemene and cetuximab is sensitive to KRAS mutant colorectal cancer cells by inducing ferroptosis and inhibiting epithelial-mesenchymal transformation","volume":"10","author":"Chen","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.ijbiomac.2026.151362_bb0215","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1038\/s41388-022-02331-9","article-title":"Deciphering the acetylation code of p53 in transcription regulation and tumor suppression","volume":"41","author":"Xia","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.ijbiomac.2026.151362_bb0220","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/s13238-011-1063-9","article-title":"The impact of acetylation and deacetylation on the p53 pathway","volume":"2","author":"Brooks","year":"2011","journal-title":"Protein Cell"},{"key":"10.1016\/j.ijbiomac.2026.151362_bb0225","doi-asserted-by":"crossref","first-page":"50607","DOI":"10.1074\/jbc.C200578200","article-title":"Acetylation of p53 inhibits its ubiquitination by Mdm2","volume":"277","author":"Li","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2026.151362_bb0230","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/jpi.12150","article-title":"Melatonin down-regulates MDM2 gene expression and enhances p53 acetylation in MCF-7 cells","volume":"57","author":"Proietti","year":"2014","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.ijbiomac.2026.151362_bb0235","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13643","article-title":"Visualization of the hepatic and renal cell uptake and trafficking of tetrahedral DNA origami in tumour","volume":"57","author":"Zhu","year":"2024","journal-title":"Cell Prolif."},{"key":"10.1016\/j.ijbiomac.2026.151362_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.jare.2025.10.052","article-title":"Tetrahedral framework nucleic acids: nanokeys unlocking a new era of precision biomedicine","author":"He","year":"2025","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.ijbiomac.2026.151362_bb0245","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3390\/mi13020315","article-title":"Therapeutic applications of programmable DNA nanostructures","volume":"13","author":"Aye","year":"2022","journal-title":"Micromachines (Basel)"},{"key":"10.1016\/j.ijbiomac.2026.151362_bb0250","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1021\/jacsau.4c01170","article-title":"Current understanding and translational prospects of tetrahedral framework nucleic acids","volume":"5","author":"Gu","year":"2025","journal-title":"JACS Au"},{"key":"10.1016\/j.ijbiomac.2026.151362_bb0255","article-title":"Efficient delivery of lomitapide using hybrid membrane-coated tetrahedral DNA nanostructures for glioblastoma therapy","volume":"36","author":"Song","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ijbiomac.2026.151362_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.126245","article-title":"Thermodynamic and cellular studies of doxorubicin\/daunorubicin loaded by a DNA tetrahedron for diagnostic imaging, chemotherapy, and gene therapy","volume":"251","author":"Li","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2026.151362_bb0265","doi-asserted-by":"crossref","first-page":"103","DOI":"10.7150\/thno.99588","article-title":"Development of dual aptamers-functionalized c-MET PROTAC degraders for targeted therapy of osteosarcoma","volume":"15","author":"Fu","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.ijbiomac.2026.151362_bb0270","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.2147\/IJN.S132929","article-title":"SL2B aptamer and folic acid dual-targeting DNA nanostructures for synergic biological effect with chemotherapy to combat colorectal cancer","volume":"12","author":"Sun","year":"2017","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ijbiomac.2026.151362_bb0275","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2147\/IJN.S437859","article-title":"SiRNF8 delivered by DNA framework nucleic acid effectively sensitizes chemotherapy in colon cancer","volume":"19","author":"Guo","year":"2024","journal-title":"Int. J. Nanomedicine"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026012882?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026012882?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T23:44:53Z","timestamp":1776123893000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813026012882"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":55,"alternative-id":["S0141813026012882"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.151362","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AS1411-aptamer-functionalized DNA tetrahedron for targeted delivery of vorinostat to suppress gastric cancer progression via ferroptosis induction and epithelial-mesenchymal transition inhibition","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.151362","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"151362"}}